DaVita, Inc. (NYSE:DVA)
CAPS Rating:
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
This company's product is absolutely unrelated to any other aspect of the economy. All dialysis patients need and will receive dialysis, regardless of economics. The government pays the bills and will continue to do so. Costs are completely predictable and the company has managed them skillfully over the past eight years.
The company can predict revenue, cost, and earnings, with almost 100% accuracy, well into the future.
This is a no-brainer.